Company / PP&E (Net)
ALX ONCOLOGY HOLDINGS INC PP&E (Net) History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$3.9M
FY2022
5-year range
$52.0K / $3.9M
FY2020-FY2022
Trend
+333.6%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) changed +334% YoY in FY2022, a notable deviation from the 2-year average annual change of +979%.
Based on SEC 10-K filings.
$4M in FY2022.
Improved from $52,000 to $4M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, pp&e (net) increased 333.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2022 | $3.9M | +333.6% |
| FY2021 | $897.0K | +1625.0% |
| FY2020 | $52.0K | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026